Double-Blind, Randomized, Multicenter, Parallel-Group Study to Evaluate the Effects of Pioglitazone on Metabolic Syndrome in Patients With Type 2 Diabetes Treated With Metformin.

Trial Profile

Double-Blind, Randomized, Multicenter, Parallel-Group Study to Evaluate the Effects of Pioglitazone on Metabolic Syndrome in Patients With Type 2 Diabetes Treated With Metformin.

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Aug 2013

At a glance

  • Drugs Metformin; Pioglitazone
  • Indications Metabolic syndrome; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms PRISMA
  • Sponsors Takeda Italia Farmaceutici
  • Most Recent Events

    • 19 Apr 2013 Primary endpoint 'HDL-cholesterol-level' has been met.
    • 25 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top